According to ChainCatcher news and Investing reports, the biological sample procurement company iSpecimen Inc. (ISPC) has announced that several Crypto Assets companies have approached it to provide investment opportunities. The company is planning to establish a digital asset library worth $200 million, aimed at diversifying its balance sheet through tokenization of real-world assets and top-ranking Crypto Assets to support its growth plans.
iSpecimen is continuing parallel discussions to develop a financial plan based on the Solana blockchain. The company plans to purchase SOL through over-the-counter transactions with crypto asset institutions, including locked SOL with contract transfer or ownership restrictions.
This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.
Biological sample procurement company iSpecimen plans to establish a $200 million digital asset repository by purchasing SOL through OTC.
According to ChainCatcher news and Investing reports, the biological sample procurement company iSpecimen Inc. (ISPC) has announced that several Crypto Assets companies have approached it to provide investment opportunities. The company is planning to establish a digital asset library worth $200 million, aimed at diversifying its balance sheet through tokenization of real-world assets and top-ranking Crypto Assets to support its growth plans. iSpecimen is continuing parallel discussions to develop a financial plan based on the Solana blockchain. The company plans to purchase SOL through over-the-counter transactions with crypto asset institutions, including locked SOL with contract transfer or ownership restrictions.